Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Ghirardelli

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Haematologica|April 6, 1999
Diagnostic approach to lymph node enlargementM L Ghirardelli, V Jemos, P G Gobbi
Haematologica|March 7, 2000
A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL)P G Gobbi, M L Ghirardelli, P Avanzini, et al.
Haematologica|July 18, 2000
Lomustine and melphalan cannot be replaced by cyclophosphamide and etoposide without reducing efficacy in MOPPEBVCAD chemotherapy for advanced Hodgkin's diseaseP G Gobbi, C Broglia, R Bertè, et al.
Haematologica|April 11, 2000
The role of surgery in the treatment of gastrointestinal lymphomas other than low-grade MALT lymphomasP G Gobbi, M L Ghirardelli, C Cavalli, et al.
Blood|May 16, 1998
Long-term results from MOPPEBVCAD chemotherapy with optional limited radiotherapy in advanced Hodgkin's diseaseP G Gobbi, C Pieresca, M L Ghirardelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Image-aided estimate of tumor burden in Hodgkin's disease: evidence of its primary prognostic importanceP G Gobbi, M L Ghirardelli, M Solcia, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Haematologica|April 6, 1999
Diagnostic approach to lymph node enlargementM L Ghirardelli, V Jemos, P G Gobbi
Haematologica|March 7, 2000
A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL)P G Gobbi, M L Ghirardelli, P Avanzini, et al.
Haematologica|July 18, 2000
Lomustine and melphalan cannot be replaced by cyclophosphamide and etoposide without reducing efficacy in MOPPEBVCAD chemotherapy for advanced Hodgkin's diseaseP G Gobbi, C Broglia, R Bertè, et al.
Haematologica|April 11, 2000
The role of surgery in the treatment of gastrointestinal lymphomas other than low-grade MALT lymphomasP G Gobbi, M L Ghirardelli, C Cavalli, et al.
Blood|May 16, 1998
Long-term results from MOPPEBVCAD chemotherapy with optional limited radiotherapy in advanced Hodgkin's diseaseP G Gobbi, C Pieresca, M L Ghirardelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Image-aided estimate of tumor burden in Hodgkin's disease: evidence of its primary prognostic importanceP G Gobbi, M L Ghirardelli, M Solcia, et al.
Pageof 1